Corporate
Halozyme Raises 2026 Guidance to $1.8B, Hits $1B Royalty Milestone a Year Early
Jan 28
You're signed outSign in or to get full access.
HALOZYME THERAPEUTICS (HALO) Earnings Call Transcripts
Browse quarterly earnings call transcripts for HALOZYME THERAPEUTICS.
Q4 2025
Feb 17, 2026
Q3 2025
Nov 3, 2025
Q2 2025
Aug 5, 2025
Q1 2025
May 6, 2025
Q4 2024
Feb 18, 2025
Q3 2024
Oct 31, 2024
Q2 2024
Aug 6, 2024
Q1 2024
May 7, 2024
Q4 2023
Feb 20, 2024
Q3 2023
Nov 6, 2023
Q2 2023
Aug 8, 2023
Q1 2023
May 9, 2023